200 related articles for article (PubMed ID: 18299678)
1. Serum prolidase activity in postmenopausal osteoporosis.
Namiduru ES; Binnur Erbagci A; Celik A; Yilmaz M; Tarakçioglu M
Minerva Med; 2007 Dec; 98(6):647-51. PubMed ID: 18299678
[TBL] [Abstract][Full Text] [Related]
2. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
3. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
6. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
7. Serum bone specific alkaline phosphatase and urinary deoxypyridinoline in postmenopausal osteoporosis.
Nawawi HM; Yazid TN; Ismail NM; Mohamad AR; Nirwana SI; Khalid BA
Malays J Pathol; 2001 Dec; 23(2):79-88. PubMed ID: 12166596
[TBL] [Abstract][Full Text] [Related]
8. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
9. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416
[TBL] [Abstract][Full Text] [Related]
10. The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women.
Celik E; Guzel S; Abali R; Guzelant AY; Celik Guzel E; Kuçukyalcin V
Minerva Med; 2013 Oct; 104(5):497-504. PubMed ID: 24101107
[TBL] [Abstract][Full Text] [Related]
11. [Is there a role for a random measurement of 24-hour urine calcium excretion and serum total alkaline phosphatase in the determination of fracture risk in osteoporotic postmenopausal women?].
Barbu C; Roman A; Rotaru R; Fica S
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):291-4. PubMed ID: 17802933
[TBL] [Abstract][Full Text] [Related]
12. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression.
Petronijević M; Petronijević N; Ivković M; Stefanović D; Radonjić N; Glisić B; Ristić G; Damjanović A; Paunović V
Bone; 2008 Mar; 42(3):582-90. PubMed ID: 18226593
[TBL] [Abstract][Full Text] [Related]
13. [Biochemical markers of bone remodeling and bone density in healthy postmenopausal women].
Campusano C; López JM; González G; Rojas A; Arteaga E; Rodríguez J
Rev Med Chil; 1993 Sep; 121(9):1000-5. PubMed ID: 8191148
[TBL] [Abstract][Full Text] [Related]
14. Assessment of bone metabolism and mineral density in chronic viral hepatitis.
Yenice N; Gümrah M; Mehtap O; Kozan A; Türkmen S
Turk J Gastroenterol; 2006 Dec; 17(4):260-6. PubMed ID: 17205403
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Migu tablet on bone mineral density, serum matrix metalloproteinase-2 level and bone metabolic markers in postmenopausal osteoporosis].
Dai Y; Shen L
Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2409-12. PubMed ID: 18257271
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women.
Kim BJ; Yu YM; Kim EN; Chung YE; Koh JM; Kim GS
Clin Endocrinol (Oxf); 2007 Jul; 67(1):152-8. PubMed ID: 17466002
[TBL] [Abstract][Full Text] [Related]
17. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
Zofkova I; Hill M
Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899
[TBL] [Abstract][Full Text] [Related]
19. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
Bai XL; Liang TB; Wu LH; Li DL; Geng L; Wang WL; Shen Y; Zhang M; Zheng SS
Transplant Proc; 2007 Dec; 39(10):3182-5. PubMed ID: 18089348
[TBL] [Abstract][Full Text] [Related]
20. [Effect of physical activity on bone turnover in young boys].
Kalaï E; Bahlous A; Nbigh A; Sahli H; Sellami S; Abdelmoula J
Ann Biol Clin (Paris); 2007; 65(5):519-24. PubMed ID: 17913670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
